Citation Impact
Citing Papers
Toll Pathway-Dependent Blockade of CD4 + CD25 + T Cell-Mediated Suppression by Dendritic Cells
2003 StandoutScience
Endotoxin-tolerant Mice Have Mutations in Toll-like Receptor 4 (Tlr4)
1999 Standout
Immunotherapy of cancer in 2012
2012
Elements of cancer immunity and the cancer–immune set point
2017 StandoutNature
Therapeutic cancer vaccines: are we there yet?
2010
Epigenetics in human disease and prospects for epigenetic therapy
2004 StandoutNature
Immunotherapy in Prostate Cancer
2015
T cell profiling reveals high CD4+CTLA-4+ T cell frequency as dominant predictor for survival after Prostate GVAX/ipilimumab treatment
2012
Dendritic Cells
2010
The power and the promise of DNA methylation markers
2003
Influence of tumour micro-environment heterogeneity on therapeutic response
2013 StandoutNature
Cancer immunotherapy via dendritic cells
2012 Standout
Combined immunotherapy with granulocyte-macrophage colony-stimulating factor-transduced allogeneic prostate cancer cells and ipilimumab in patients with metastatic castration-resistant prostate cancer: a phase 1 dose-escalation trial
2012
Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease
2001 StandoutNature
Structural and physicochemical requirements of endotoxins for the activation of arachidonic acid metabolism in mouse peritoneal macrophages in vitro
1989
Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse
2001 StandoutNobel
Transforming growth factor-β induces development of the TH17 lineage
2006 StandoutNature
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Immune Checkpoint Targeting in Cancer Therapy: Toward Combination Strategies with Curative Potential
2015 StandoutNobel
Toll-like receptors in the induction of the innate immune response
2000 StandoutNature
Interleukin-10-deficient mice develop chronic enterocolitis
1993 Standout
Novel cancer immunotherapy agents with survival benefit: recent successes and next steps
2011 StandoutNobel
Angiogenesis in life, disease and medicine
2005 StandoutNature
Lipopolysaccharide (LPS) recognition in macrophages. Participation of LPS-binding protein and CD14 in LPS-induced adaptation in rabbit peritoneal exudate macrophages.
1993
Improved Endpoints for Cancer Immunotherapy Trials
2010
Integrated data from 2 randomized, double‐blind, placebo‐controlled, phase 3 trials of active cellular immunotherapy with sipuleucel‐T in advanced prostate cancer
2009
The immune response of Drosophila
2003 StandoutNatureNobel
mRNA vaccine with unmodified uridine induces robust type I interferon-dependent anti-tumor immunity in a melanoma model
2022 StandoutNobel
Primary, Adaptive, and Acquired Resistance to Cancer Immunotherapy
2017 Standout
Cancer immunotherapy comes of age
2011 StandoutNature
The immune contexture in human tumours: impact on clinical outcome
2012 Standout
Participation of tumor necrosis factor in the mediation of gram negative bacterial lipopolysaccharide-induced injury in rabbits.
1988
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer
2010 Standout
Spontaneous, heritable colitis in a new substrain of C3H/HeJ mice
1994
Targeted disruption of the mouse transforming growth factor-β1 gene results in multifocal inflammatory disease
1992 StandoutNature
Therapeutic vaccines for cancer: an overview of clinical trials
2014
Melanoma-intrinsic β-catenin signalling prevents anti-tumour immunity
2015 StandoutNature
Points of control in inflammation
2002 StandoutNature
The anti-angiogenic basis of metronomic chemotherapy
2004 Standout
Secretory Leukocyte Protease Inhibitor: A Macrophage Product Induced by and Antagonistic to Bacterial Lipopolysaccharide
1997
Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
2006
TGFα deficiency results in hair follicle and eye abnormalities in targeted and waved-1 mice
1993 StandoutNobel
Pervasive Adaptive Evolution in Primate Seminal Proteins
2005
Angiogenesis as a therapeutic target
2005 StandoutNature
Cancer immunology—analysis of host and tumor factors for personalized medicine
2011
Physical contact between lipopolysaccharide and Toll-like receptor 4 revealed by genetic complementation
2000 StandoutNobel
Recent Developments in Cancer Vaccines
2011
Defective LPS Signaling in C3H/HeJ and C57BL/10ScCr Mice: Mutations in Tlr4 Gene
1998 StandoutScienceNobel
Cancer Vaccines in the World of Immune Suppressive Monocytes (CD14+HLA-DRlo/neg Cells): The Gateway to Improved Responses
2014
Cachectin and tumour necrosis factor as two sides of the same biological coin
1986 StandoutNatureNobel
Adoptive cell transfer as personalized immunotherapy for human cancer
2015 StandoutScience
Structure and Function of Lipopolysaccharide Binding Protein
1990 StandoutScience
Shock and Tissue Injury Induced by Recombinant Human Cachectin
1986 StandoutScienceNobel
Integrated NY-ESO-1 antibody and CD8+T-cell responses correlate with clinical benefit in advanced melanoma patients treated with ipilimumab
2011 StandoutNobel
Cancer Immunotherapy Comes of Age
2011
The Primary Role of Lymphoreticnlar Cells in the Mediation of Host Responses to Bacterial Endotoxim
1980
Lack of a role for transforming growth factor-β in cytotoxic T lymphocyte antigen-4-mediated inhibition of T cell activation
2001 StandoutNobel
A Transgenic Model of Visceral Obesity and the Metabolic Syndrome
2001 StandoutScience
Action of Endotoxin on Lymphoid Cells
1977
Nod2-Dependent Regulation of Innate and Adaptive Immunity in the Intestinal Tract
2005 StandoutScience
Cachectin: More Than a Tumor Necrosis Factor
1987 StandoutNobel
Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer.
1994 StandoutNobel
Apolipoprotein E: Cholesterol Transport Protein with Expanding Role in Cell Biology
1988 StandoutScience
The future of immune checkpoint therapy
2015 StandoutScienceNobel
Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin
1986
Cancer Genome Landscapes
2013 StandoutScience
Precision glycocalyx editing as a strategy for cancer immunotherapy
2016 StandoutNobel
Paradigm Shifts in Cancer Vaccine Therapy
2008
Normalization of Tumor Vasculature: An Emerging Concept in Antiangiogenic Therapy
2005 StandoutScience
Clonal expansion of CD8 T cells in the systemic circulation precedes development of ipilimumab-induced toxicities
2016 StandoutNobel
Anti-CCR4 mAb selectively depletes effector-type FoxP3+CD4+regulatory T cells, evoking antitumor immune responses in humans
2013 StandoutNobel
Mutations in mouse Aspm (abnormal spindle-like microcephaly associated) cause not only microcephaly but also major defects in the germline
2010 StandoutNobel
Macrophages from Babesia and malaria infected mice are primed for monokine release
1984
Endotoxin suppresses expression of apoprotein E by mouse macrophages in vivo and in culture. A biochemical and genetic study.
1983
Therapeutic cancer vaccines
2015
Characterization of macrophage function in Mycobacterium lepraemurium‐infected mice: sensitivity of mice to endotoxin and release of mediators and lysosomal enzymes after endotoxin treatment
1983
Phylogenetic Perspectives in Innate Immunity
1999 StandoutScienceNobel
Targeted expression of a toxin gene to adipose tissue: transgenic mice resistant to obesity.
1993
Mitogenic stimulation of murine spleen cells: relation to susceptibility to Salmonella infection
1977
Works of L. Michael Glodé being referenced
Comparison of telomerase activity and GSTP1 promoter methylation in ejaculate as potential screening tests for prostate cancer
2000
A comprehensive characterization of the peptide and protein constituents of human seminal fluid
2004
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma
2003
Targeted Ablation of Pituitary Gonadotropes in Transgenic Mice
1991
Difference in B Cell Mitogen Responsiveness Between Closely Related Strains of Mice
1975
Overall Survival Analysis of a Phase II Randomized Controlled Trial of a Poxviral-Based PSA-Targeted Immunotherapy in Metastatic Castration-Resistant Prostate Cancer
2010
Randomized Trial of Autologous Cellular Immunotherapy with Sipuleucel-T in Androgen-Dependent Prostate Cancer
2011
Genetic Control of B Cell Activation by Bacterial Lipopolysaccharide Is Mediated by Multiple Distinct Genes or Alleles
1976
Randomized, double-blind, vector-controlled study of targeted immunotherapy in patients (pts) with hormone-refractory prostate cancer (HRPC)
2006
Significant contribution of spleen cells in mediating the lethal effects of endotoxin in vivo
1976
Resistance of Macrophages from C3H/HeJ Mice to the in Vitro Cytotoxic Effects of Endotoxin
1977
Lack of Responsiveness of C3H/HeJ Macrophages to Lipopolysaccharide: The Cellular Basis of LPS-Stimulated Metabolism
1979
Defective prostaglandin synthesis by C3H/HeJ mouse macrophages stimulated with endotoxin preparations
1979
Cellular Mechanism of Endotoxin Unresponsiveness in C3H/HeJ Mice
1976